Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Auditor change
Consulting agrmnt
|
|
PIERIS PHARMACEUTICALS, INC. (PIRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Lynx1 Capital Management LP reports a 7.6% stake in Pieris Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 7.5% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| ASTRAZENECA PLC reports a 4.8% stake in PIERIS PHARMACEUTICALS, INC. |
| 01/26/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 1.3% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 5.9% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Pieris Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 4.5% stake in Pieris Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Nussbaum Ran reports a 5% stake in PIERIS PHARMACEUTICALS, INC. |
| 07/12/2021 |
SC 13G/A
| BlackRock Inc. reports a 2.1% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/16/2021 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 8.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 6.5% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/19/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 9.9% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/12/2018 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10.4% stake in Pieris Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Global Life Bioventure IV S.a.r.l. reports a 3.9% stake in Pieris Pharmaceuticals, Inc. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/25/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|